Pregabalin
Product Description
Beijing Double-Crane Pharmaceutical Equipment Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2022
-
Certificates:5
-
Employees:5000+
Company types
Primary activities
Specifications
Beijing Double-Crane Pharmaceutical Equipment Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2022
-
Certificates:5
-
Employees:5000+
Company types
Primary activities
More Products from Beijing Double-Crane Pharmaceutical Equipment Co.,Ltd. (4)
-
Product Allopurinol
Allopurinol is one of our mature products. With the strong strength of CR Double-Crane Pharmaceutical Co., Ltd., our company keeps improving and optimizing the production, R&D, technology and equipment to ensure the product quality fully meets the requirements at home and abroad. To ensure the quali... -
Product Isoniazid
Isoniazid is one of our mature products, with an annual production capacity of 350mt/year. With the strong strength of China Resources Double-Crane Pharmaceutical Co., Ltd., our company has continuously improved and optimized production, R & D, technology and equipments to ensure that the product q... -
Product Varsaltan
Valsartan is one of our mature products, with an annual production capacity of 240mt/year. With the strong strength of China Resources Double-Crane Pharmaceutical Co., Ltd., our company has continuously improved and optimized production, R & D, technology and equipments to ensure that the product quali... -
Product Coenzyme Q10 /Coenzima q10 USP / EP
Coenzyme Q10
Coenzyme Q10 10% CWS
Coenzyme Q10 20% CWS
Coenzyme Q10 40% CWS
Specification: USP/EP/JP
Package: 1kg/bag, 5kg/drum, 10kg/drum, 25kg /drum, 20kg/carton Approved Certifications :
HACCP, USP, KOSHER, HALAL, ISO9001, DRUG MANUFACTUR...
Beijing Double-Crane Pharmaceutical Equipment Co.,Ltd. resources (1)
-
Brochure Company introduction
Five production bases,GMP-Certified Manufacturer of APIs,With FDA, CEP, WHO etc
China Resource Double-Crane Pharmaceutical Co., Ltd API Division has 5 production bases in total. At present, it has about 1300 employees, of which 200 is for R&D. It covers an area of about 600,000 square meters, has more than 50 products, has sales and registrations in more than 30 countries and regions, and has a relatively complete API research, production and marketing integration capability.
Strong products: Varsaltan,Allopurinol,Isoniazid, Pregabalin,Nicotinamide, Bendazole Hydrochloride, Amlodipine Besylate,Terazosin HCL, Sulfamethazine,
Olmesartan Medoxomil,Azilsartan,Pitavastatin Calcium, Sodium Nitroprusside,Triamterenum.



